primaryid string | caseid string | caseversion string | i_f_code string | event_dt string | mfr_dt string | init_fda_dt string | fda_dt string | rept_cod string | auth_num string | mfr_num string | mfr_sndr string | lit_ref string | age string | age_cod string | age_grp string | sex string | e_sub string | wt string | wt_cod string | rept_dt string | to_mfr string | occp_cod string | reporter_country string | occr_country string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
228581751 | 22858175 | 1 | I | 20230816 | 20230822 | 20230824 | 20230824 | EXP | null | US-ROCHE-3409974 | ROCHE | null | 63 | YR | null | F | Y | null | null | 20230824 | null | CN | US | null |
228581761 | 22858176 | 1 | I | 20230801 | 20230818 | 20230824 | 20230824 | PER | null | US-UNITED THERAPEUTICS-UNT-2023-023867 | UNITED THERAPEUTICS | null | 73 | YR | null | F | Y | 44.898 | KG | 20230824 | null | CN | US | US |
228581771 | 22858177 | 1 | I | 20230801 | 20230821 | 20230824 | 20230824 | EXP | null | DE-ABBVIE-5378826 | ABBVIE | null | 73 | YR | null | M | Y | null | null | 20230824 | null | CN | DE | DE |
228581781 | 22858178 | 1 | I | null | 20230726 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017464 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228581791 | 22858179 | 1 | I | null | 20230823 | 20230824 | 20230824 | PER | null | US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-257194 | BOEHRINGER INGELHEIM | null | 86 | YR | E | M | Y | null | null | 20230824 | null | CN | US | US |
228581801 | 22858180 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023149549 | AMGEN | null | null | null | null | null | Y | null | null | 20230823 | null | PH | US | US |
228581811 | 22858181 | 1 | I | null | 20230814 | 20230824 | 20230824 | EXP | null | US-ELI_LILLY_AND_COMPANY-US202106014676 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228581831 | 22858183 | 1 | I | 20230806 | 20230817 | 20230824 | 20230824 | EXP | null | US-ELI_LILLY_AND_COMPANY-US202308011458 | ELI LILLY AND CO | null | null | null | A | F | Y | null | null | 20230824 | null | CN | US | US |
228581841 | 22858184 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308013950 | ELI LILLY AND CO | null | null | null | null | null | Y | null | null | 20230824 | null | HP | US | US |
228581851 | 22858185 | 1 | I | null | 20230818 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308012240 | ELI LILLY AND CO | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228581861 | 22858186 | 1 | I | 20230427 | 20230815 | 20230824 | 20230824 | EXP | null | US-ELI_LILLY_AND_COMPANY-US202308011658 | ELI LILLY AND CO | null | 26 | YR | null | F | Y | null | null | 20230824 | null | CN | US | US |
228581871 | 22858187 | 1 | I | null | 20230815 | 20230824 | 20230824 | EXP | null | BR-ELI_LILLY_AND_COMPANY-BR202308009768 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | BR | BR |
228581881 | 22858188 | 1 | I | null | 20230817 | 20230824 | 20230824 | EXP | null | US-ELI_LILLY_AND_COMPANY-US202308011643 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228581892 | 22858189 | 2 | F | null | 20230914 | 20230824 | 20230920 | EXP | null | JP-ELI_LILLY_AND_COMPANY-JP202308010853 | ELI LILLY AND CO | null | 55 | YR | null | F | Y | null | null | 20230920 | null | CN | JP | JP |
228581901 | 22858190 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-ELI_LILLY_AND_COMPANY-US202308013985 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228581914 | 22858191 | 4 | F | 20200101 | 20230831 | 20230824 | 20230915 | EXP | null | BR-ELI_LILLY_AND_COMPANY-BR202308010659 | ELI LILLY AND CO | null | null | null | null | F | Y | null | null | 20230914 | null | CN | BR | BR |
228581921 | 22858192 | 1 | I | 20230817 | 20230817 | 20230824 | 20230824 | EXP | null | US-ELI_LILLY_AND_COMPANY-US202308012561 | ELI LILLY AND CO | null | 80 | YR | null | F | Y | null | null | 20230824 | null | CN | US | US |
228581931 | 22858193 | 1 | I | null | 20230801 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017534 | SANDOZ | null | null | null | null | F | Y | 104.55 | KG | 20230824 | null | HP | US | US |
228581941 | 22858194 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-118929 | BRISTOL MYERS SQUIBB | null | 81 | YR | E | F | Y | 61.69 | KG | 20230824 | null | HP | US | US |
228581951 | 22858195 | 1 | I | 20230201 | 20230814 | 20230824 | 20230824 | EXP | null | DE-ABBVIE-5367666 | ABBVIE | null | 64 | YR | null | M | Y | null | null | 20230824 | null | CN | DE | DE |
228581972 | 22858197 | 2 | F | 20230205 | 20230905 | 20230824 | 20230909 | 30DAY | null | EG-SANDOZ INC.-SDZ2023EG017745 | SANDOZ | null | 11 | YR | null | M | Y | 26 | KG | 20230909 | null | CN | EG | EG |
228581981 | 22858198 | 1 | I | null | 20230817 | 20230824 | 20230824 | PER | null | US-JNJFOC-20230845906 | JOHNSON AND JOHNSON | null | null | null | A | F | Y | null | null | 20230824 | null | HP | US | US |
228581991 | 22858199 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-ABBVIE-5379373 | ABBVIE | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | US |
228582011 | 22858201 | 1 | I | null | 20230810 | 20230824 | 20230824 | EXP | null | CA-AUROBINDO-AUR-APL-2023-054108 | AUROBINDO | null | 50 | YR | null | F | Y | null | null | 20230824 | null | MD | CA | CA |
228582021 | 22858202 | 1 | I | null | 20230608 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017463 | SANDOZ | null | null | null | null | M | Y | 100 | KG | 20230824 | null | HP | US | US |
228582031 | 22858203 | 1 | I | 20230810 | 20230811 | 20230824 | 20230824 | EXP | null | US-Accord-374062 | ACCORD | null | 65 | YR | E | M | Y | null | null | 20230823 | null | HP | US | US |
228582041 | 22858204 | 1 | I | 20230314 | 20230811 | 20230824 | 20230824 | EXP | ES-AEMPS-1396339 | ES-Accord-374168 | ACCORD | null | 60 | YR | A | M | Y | null | null | 20230823 | null | MD | ES | ES |
228582051 | 22858205 | 1 | I | 20160729 | 20230811 | 20230824 | 20230824 | EXP | DE-EMA-DD-20191219-sahu_k-154547 | DE-Accord-167809 | ACCORD | null | 67 | YR | E | M | Y | 67 | KG | 20230823 | null | MD | DE | DE |
228582062 | 22858206 | 2 | F | 20230817 | 20230823 | 20230824 | 20230828 | EXP | null | AR-AMGEN-ARGSP2023148710 | AMGEN | null | 63 | YR | A | M | Y | null | null | 20230828 | null | CN | AR | AR |
228582071 | 22858207 | 1 | I | null | 20230813 | 20230824 | 20230824 | EXP | GB-MHRA-ADR 28117266 | GB-Accord-374140 | ACCORD | null | 22 | YR | A | M | Y | null | null | 20230823 | null | HP | GB | GB |
228582081 | 22858208 | 1 | I | 20210518 | 20230811 | 20230824 | 20230824 | EXP | PL-URPL-DML-MLP.4401.1.3100.2021 | PL-Accord-374147 | ACCORD | null | 76 | YR | E | F | Y | 74 | KG | 20230823 | null | MD | PL | PL |
228582091 | 22858209 | 1 | I | null | 20230814 | 20230824 | 20230824 | EXP | null | US-AMGEN-USASP2023145883 | AMGEN | Levy E.; Pfalzer L. A.. NEW LYMPHATIC CORDING AS A PRECURSOR TO DETECTION OF RECURRENT BREAST CANCER: A CASE REPORT. Rehabilitation oncology. 2016;34 (1):E11 | 43 | YR | A | F | Y | null | null | 20230823 | null | HP | US | US |
228582111 | 22858211 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017560 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | MD | US | US |
228582121 | 22858212 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | DE-SANDOZ-SDZ2023DE017290 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | CN | DE | DE |
228582131 | 22858213 | 1 | I | 20230526 | 20230811 | 20230824 | 20230824 | EXP | FR-EMA-2023714-AUTODUP-1689370267402 | FR-Accord-374157 | ACCORD | null | 96 | YR | E | F | Y | 97 | KG | 20230823 | null | MD | FR | FR |
228582161 | 22858216 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | US-ABBVIE-5378212 | ABBVIE | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582171 | 22858217 | 1 | I | 20230707 | 20230814 | 20230824 | 20230824 | EXP | null | PT-GLAXOSMITHKLINE-PTCH2023HLN040413 | GLAXOSMITHKLINE | null | null | null | null | null | Y | null | null | 20230824 | null | PH | PT | PT |
228582181 | 22858218 | 1 | I | 20230716 | 20230819 | 20230824 | 20230824 | EXP | null | CN-GLAXOSMITHKLINE-CNCH2023APC040343 | GLAXOSMITHKLINE | null | null | null | null | null | Y | null | null | 20230824 | null | HP | CN | CN |
228582191 | 22858219 | 1 | I | null | 20230818 | 20230824 | 20230824 | 30DAY | null | US-GSK-US2023112606 | GLAXOSMITHKLINE | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582201 | 22858220 | 1 | I | null | 20230816 | 20230824 | 20230824 | 30DAY | null | US-GSK-US2023111538 | GLAXOSMITHKLINE | null | 80 | YR | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582211 | 22858221 | 1 | I | 20230801 | 20230816 | 20230824 | 20230824 | EXP | null | CN-GLAXOSMITHKLINE-CNCH2023APC040319 | GLAXOSMITHKLINE | null | null | null | null | null | Y | null | null | 20230824 | null | HP | CN | CN |
228582221 | 22858222 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-AMGEN-USASP2023145171 | AMGEN | Rossoff J.; Elhodaky M.; Gunderman L. M. et al.. Relapse of large B-cell lymphoma with IRT4 rearrangement associated with SLAM-associated protein deficiency. Pediatric Blood + Cancer. 2023;70 (9):1-4 | 7 | YR | C | M | Y | null | null | 20230823 | null | HP | US | US |
228582242 | 22858224 | 2 | F | null | 20230829 | 20230824 | 20230901 | EXP | null | US-ABBVIE-5378232 | ABBVIE | null | null | null | null | F | Y | null | null | 20230901 | null | CN | US | US |
228582251 | 22858225 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | CA-CELLTRION INC.-2023CA016646 | CELLTRION | null | null | null | null | null | Y | null | null | 20230824 | null | MD | CA | CA |
228582261 | 22858226 | 1 | I | null | 20230726 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017605 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | MD | US | US |
228582271 | 22858227 | 1 | I | 20230406 | 20230822 | 20230824 | 20230824 | EXP | null | NVSC2023US183802 | NOVARTIS | null | 72 | YR | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582291 | 22858229 | 1 | I | null | 20230817 | 20230824 | 20230824 | PER | null | US-JNJFOC-20230842967 | JOHNSON AND JOHNSON | null | null | null | null | M | Y | null | null | 20230824 | null | HP | US | US |
228582302 | 22858230 | 2 | F | null | 20230817 | 20230824 | 20230828 | EXP | null | US-JNJFOC-20230839848 | JOHNSON AND JOHNSON | null | 4 | DEC | A | null | Y | null | null | 20230828 | null | HP | US | US |
228582311 | 22858231 | 1 | I | null | 20230607 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017526 | SANDOZ | null | null | null | null | F | Y | 93.18 | KG | 20230824 | null | MD | US | US |
228582321 | 22858232 | 1 | I | null | 20230817 | 20230824 | 20230824 | PER | null | US-JNJFOC-20230844847 | JOHNSON AND JOHNSON | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582331 | 22858233 | 1 | I | 20230101 | 20230821 | 20230824 | 20230824 | EXP | null | US-BRISTOL-MYERS SQUIBB COMPANY-2023-117621 | BRISTOL MYERS SQUIBB | null | 75 | YR | E | M | Y | null | null | 20230824 | null | HP | US | US |
228582341 | 22858234 | 1 | I | null | 20230726 | 20230824 | 20230824 | EXP | null | US-002147023-NVSC2023US126383 | SANDOZ | null | null | null | null | F | Y | 73 | KG | 20230824 | null | HP | US | US |
228582371 | 22858237 | 1 | I | null | 20230811 | 20230824 | 20230824 | EXP | null | US-LEO Pharma-362129 | LEO PHARM | null | 60 | YR | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582391 | 22858239 | 1 | I | null | 20230815 | 20230824 | 20230824 | EXP | null | US-INTERCEPT-PM2023001503 | INTERCEPT PHARMACEUTICALS | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582412 | 22858241 | 2 | F | 20230821 | 20230824 | 20230824 | 20230828 | PER | null | US-AMGEN-USASP2023148342 | AMGEN | null | null | null | null | null | Y | null | null | 20230828 | null | PH | US | US |
228582432 | 22858243 | 2 | F | 20230818 | 20230908 | 20230824 | 20230913 | PER | null | US-AMGEN-USASP2023149452 | AMGEN | null | 71 | YR | E | M | Y | null | null | 20230913 | null | CN | US | US |
228582441 | 22858244 | 1 | I | 20230628 | 20230811 | 20230824 | 20230824 | EXP | null | US-ROCHE-3374567 | ROCHE | null | 76 | YR | null | F | Y | null | null | 20230824 | null | HP | US | null |
228582461 | 22858246 | 1 | I | null | 20230717 | 20230824 | 20230824 | EXP | null | AR-SANDOZ-SDZ2023AR017446 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | CN | AR | AR |
228582471 | 22858247 | 1 | I | 20230722 | 20230815 | 20230824 | 20230824 | EXP | null | CN-SANDOZ-SDZ2023CN017005 | SANDOZ | null | 76 | YR | null | M | Y | 60 | KG | 20230824 | null | HP | CN | CN |
228582491 | 22858249 | 1 | I | null | 20230817 | 20230824 | 20230824 | 30DAY | null | US-GSK-US2023112656 | GLAXOSMITHKLINE | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582511 | 22858251 | 1 | I | null | 20230815 | 20230824 | 20230824 | EXP | null | GB-HETERO-AMR2023GB02372 | HETERO | null | 58 | YR | null | F | Y | 126 | KG | 20230824 | null | CN | GB | GB |
228582522 | 22858252 | 2 | F | 20210101 | 20230823 | 20230824 | 20230825 | EXP | null | US-ABBVIE-5379333 | ABBVIE | null | 38 | YR | null | M | Y | 112 | KG | 20230825 | null | MD | US | FR |
228582531 | 22858253 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | GB-SANDOZ-SDZ2023GB017367 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | HP | GB | GB |
228582541 | 22858254 | 1 | I | null | 20230817 | 20230824 | 20230824 | PER | null | US-JNJFOC-20230842304 | JOHNSON AND JOHNSON | null | null | null | A | F | Y | null | null | 20230824 | null | MD | US | US |
228582561 | 22858256 | 1 | I | null | 20230819 | 20230824 | 20230824 | EXP | null | US-JAZZ PHARMACEUTICALS-2023-US-017723 | JAZZ | null | 16 | YR | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582571 | 22858257 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023148003 | AMGEN | null | null | null | null | F | Y | null | null | 20230823 | null | CN | US | US |
228582591 | 22858259 | 1 | I | 20230601 | 20230818 | 20230824 | 20230824 | PER | null | US-ABBVIE-5375189 | ABBVIE | null | 38 | YR | null | M | Y | 122 | KG | 20230824 | null | CN | US | US |
228582601 | 22858260 | 1 | I | null | 20230531 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017508 | SANDOZ | null | null | null | null | M | Y | 113.39 | KG | 20230824 | null | MD | US | US |
228582611 | 22858261 | 1 | I | null | 20230607 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017500 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | MD | US | US |
228582621 | 22858262 | 1 | I | null | 20230817 | 20230824 | 20230824 | EXP | null | FR-BRISTOL-MYERS SQUIBB COMPANY-2023-117743 | BRISTOL MYERS SQUIBB | null | null | null | null | null | Y | null | null | 20230824 | null | MD | FR | FR |
228582631 | 22858263 | 1 | I | null | 20230726 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017442 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | MD | US | US |
228582641 | 22858264 | 1 | I | null | 20230822 | 20230824 | 20230824 | EXP | null | NVSC2023US183580 | NOVARTIS | null | null | null | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582651 | 22858265 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-TAKEDA-2023TUS081829 | TAKEDA | null | null | null | null | F | Y | 84 | KG | 20230824 | null | MD | US | US |
228582671 | 22858267 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023148850 | AMGEN | null | null | null | null | F | Y | null | null | 20230823 | null | CN | US | US |
228582681 | 22858268 | 1 | I | null | 20230726 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017484 | SANDOZ | null | null | null | null | F | Y | null | null | 20230824 | null | MD | US | US |
228582692 | 22858269 | 2 | F | null | 20230728 | 20230824 | 20230907 | 30DAY | null | US-GSK-US2023112671 | GLAXOSMITHKLINE | null | null | null | null | F | Y | null | null | 20230907 | null | CN | US | US |
228582701 | 22858270 | 1 | I | 20230101 | 20230814 | 20230824 | 20230824 | 30DAY | null | US-GSK-US2023AMR110853 | GLAXOSMITHKLINE | null | null | null | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582712 | 22858271 | 2 | F | 20230511 | 20230829 | 20230824 | 20230901 | EXP | null | JP-GSK-JP2023040960 | GLAXOSMITHKLINE | null | null | null | null | null | Y | null | null | 20230901 | null | MD | JP | JP |
228582721 | 22858272 | 1 | I | 20230711 | 20230818 | 20230824 | 20230824 | 30DAY | null | US-GSK-US2023112624 | GLAXOSMITHKLINE | null | 71 | YR | null | M | Y | null | null | 20230824 | null | CN | US | US |
228582731 | 22858273 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-GLAXOSMITHKLINE-USCH2023040720 | GLAXOSMITHKLINE | null | 67 | YR | null | F | Y | null | null | 20230824 | null | CN | US | US |
228582741 | 22858274 | 1 | I | 20230806 | 20230814 | 20230824 | 20230824 | EXP | null | CO-BAXTER-2023BAX028709 | BAXTER | null | 65 | YR | null | F | Y | null | null | 20230824 | null | HP | CO | CO |
228582751 | 22858275 | 1 | I | 20230625 | 20230821 | 20230824 | 20230824 | EXP | FR-AFSSAPS-CN2023000744 | FR-BRISTOL-MYERS SQUIBB COMPANY-2023-117554 | BRISTOL MYERS SQUIBB | null | 78 | YR | E | M | Y | 58 | KG | 20230824 | null | MD | FR | FR |
228582761 | 22858276 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-ABBVIE-5379631 | ABBVIE | null | null | null | null | F | Y | null | null | 20230824 | null | MD | US | US |
228582771 | 22858277 | 1 | I | null | 20230817 | 20230824 | 20230824 | EXP | null | CA-BAXTER-2023BAX028926 | BAXTER | null | null | null | null | F | Y | null | null | 20230824 | null | MD | CA | CA |
228582791 | 22858279 | 1 | I | null | 20230620 | 20230824 | 20230824 | EXP | null | US-SANDOZ-SDZ2023US017512 | SANDOZ | null | null | null | null | F | Y | 90.71 | KG | 20230824 | null | MD | US | US |
228582801 | 22858280 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | US-002147023-NVSC2023US140120 | SANDOZ | null | null | null | null | F | Y | 72.562 | KG | 20230824 | null | MD | US | US |
228582811 | 22858281 | 1 | I | null | 20230822 | 20230824 | 20230824 | PER | null | US-ABBVIE-5379454 | ABBVIE | null | 20 | YR | null | M | Y | null | null | 20230824 | null | MD | US | US |
228582821 | 22858282 | 1 | I | 20200818 | 20230818 | 20230824 | 20230824 | EXP | null | US-ROCHE-3408753 | ROCHE | null | null | null | null | null | Y | null | null | 20230824 | null | MD | US | null |
228582831 | 22858283 | 1 | I | null | 20230821 | 20230824 | 20230824 | PER | null | US-AMGEN-USASP2023149394 | AMGEN | null | null | null | null | null | Y | null | null | 20230823 | null | CN | US | US |
228582841 | 22858284 | 1 | I | null | 20230717 | 20230824 | 20230824 | EXP | null | CA-SANDOZ-SDZ2023CA017545 | SANDOZ | null | null | null | null | M | Y | null | null | 20230824 | null | MD | CA | CA |
228582851 | 22858285 | 1 | I | null | 20230726 | 20230824 | 20230824 | EXP | null | US-SANDOZ INC.-SDZ2023US017185 | SANDOZ | null | null | null | null | F | Y | 69.09 | KG | 20230824 | null | HP | US | US |
228582861 | 22858286 | 1 | I | null | 20230811 | 20230824 | 20230824 | EXP | null | US-MALLINCKRODT-MNK202303788 | MALLINCKRODT | null | null | null | E | F | Y | null | null | 20230824 | null | CN | US | US |
228582871 | 22858287 | 1 | I | null | 20230817 | 20230824 | 20230824 | EXP | null | CA-SANDOZ-SDZ2023CA017052 | SANDOZ | null | null | null | E | M | Y | null | null | 20230824 | null | CN | CA | CA |
228582881 | 22858288 | 1 | I | 20230406 | 20230810 | 20230824 | 20230824 | EXP | FR-AFSSAPS-MP2023000862 | FR-drreddys-SPO/FRA/23/0174959 | DR REDDYS | null | 79 | YR | E | M | Y | 72 | KG | 20230824 | null | MD | FR | FR |
228582891 | 22858289 | 1 | I | 20230320 | 20230810 | 20230824 | 20230824 | EXP | FR-AFSSAPS-PC2023000409 | FR-drreddys-SPO/FRA/23/0174967 | DR REDDYS | null | 73 | YR | E | M | Y | 71 | KG | 20230824 | null | HP | FR | FR |
228582901 | 22858290 | 1 | I | 20230802 | 20230818 | 20230824 | 20230824 | EXP | null | US-ABBVIE-5378026 | ABBVIE | null | null | null | I | null | Y | null | null | 20230824 | null | HP | US | US |
228582911 | 22858291 | 1 | I | 20161026 | 20230505 | 20230824 | 20230824 | EXP | null | US-ENDO PHARMACEUTICALS INC-2023-001936 | ENDO | null | null | null | null | null | Y | null | null | 20230824 | null | CN | US | US |
228582931 | 22858293 | 1 | I | null | 20230818 | 20230824 | 20230824 | EXP | null | CL-002147023-NVSC2023CL132902 | SANDOZ | null | 16 | YR | null | M | Y | 45 | KG | 20230824 | null | CN | CL | CL |
228582951 | 22858295 | 1 | I | null | 20230816 | 20230824 | 20230824 | EXP | null | US-NOVITIUMPHARMA-2023USNVP01387 | NOVITIUM PHARMA | Abdullahi Sulaiman.DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AS A CAUSE OF IGA NEPHROPATHY.American Journal of Kidney Diseases.01-APR-2023;81(4):S9-S10 | 71 | YR | E | F | Y | null | null | 20230824 | null | HP | US | US |
228582961 | 22858296 | 1 | I | 20230101 | 20230821 | 20230824 | 20230824 | PER | null | US-JNJFOC-20230850702 | JOHNSON AND JOHNSON | null | 20 | YR | A | F | Y | null | null | 20230824 | null | MD | US | US |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.